Conference Activities & Talks -

Division display  1 - 20 of about 155 ／  All the affair displays >>

  1. Koki Enomoto, Soichiro Yoshida, Haruto Izumi, Sho Uehara, Yoh Matsuoka, Kohei Yamamoto, Daisuke Hirahara, Tatsunori Saho, Eichi Takaya, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Kenichi Ohashi, Yasuhisa Fujii. Are there differences in MRI findings between cribriform and non-cribriform cancer? An analysis using radiomics and delta-radiomics. "AUA annual meeting 2024 2024.05.04

  2. 吉田　宗一郎. Phase Ⅰ/Ⅱa Trial of 18F-prostate Specific Membrane Antigen(PSMA)PET/CT in Healthy Volunteers and Prostate Cancer Patients. 第111回日本泌尿器科学会総会 2024.04.25

  3. 吉田　宗一郎. The Impact of Next Generation Imaging Modalities on Prostate Cancer Treatment.. 第111回日本泌尿器科学会総会 2024.04.25

  4. 吉田　宗一郎. Local therapy for primary and metastatic lesions in metastatic prostate cancer: treatment strategies and case discussions from a urologist's perspective. 第111回日本泌尿器科学会総会 2024.04.25

  5. Yoshida S, Kimura K, Ikeda M, Fukui K, Tsuchiya J, Nakamura Y, Waseda Y, Tanaka H, Tateishi U, Fujii Y.. Quantitative MRI Parameters Providing the Novel Value in Discriminating Muscle-Invasive Bladder Cancer.. The 39th Annual Congress of the European Association of Urology 2024.04.06

  6. Y. Ishikawa, S. Uehara, K. Ishihara, K. Hirose, T. Soma, M. Fujiwara, M. Kobayashi, B. Fan, Y. Nakamura, Y. Uchida, S. Fukuda, H. Tanaka, S. Yoshida, M. Yokoyama, Y. Matsuoka, Y. Fujii. Variability in diagnostic performance of non-muscle invasive bladder cancer for each region using 8uorescence cystoscopy with orally administered 5-aminolevulinic acid. 37th Annual EAU Congress 2022 European Association of Urology 2022.07.01

  7. Y. Ishikawa, S. Uehara, K. Ishihara, K. Hirose, T. Soma, M. Fujiwara, M. Kobayashi, B. Fan, Y. Nakamura, Y. Uchida, S. Fukuda, H. Tanaka, S. Yoshida, M. Yokoyama, Y. Matsuoka, Y. Fujii. Orally administered 5-aminolevulinic acid can cause intraoperative hypotension in patients with bladder cancer undergoing transurethral resection. 37th Annual EAU Congress 2022 European Association of Urology 2022.07.01

  8. Ishikawa Y, Sho U, Ishihara K, Hirose K, Soma T, Fujiwara M, Kobayashi M, Fan B, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Orally administered 5-aminolevulinic acid can cause intraoperative hypotension in patients with bladder cancer undergoing transurethral resection. the 37th Annual European Association of Urology(EAU) Congress 2022.07

  9. Uehara S, Matsuoka Y, Yamamoto K, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Ohashi K, Fujii Y. MRI and MRI-targeted biopsy can detect cribriform cancer of the prostate. the 37th Annual European Association of Urology(EAU) Congress 2022.07

  10. Izumi H, Uehara S, Matsuoka Y, Yamamoto K, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Ohashi K, Fujii Y. Cribriform cancer is equally visible to non-cribriform cancer on multiparametric MRI: An analysis using texture features. the 37th Annual European Association of Urology(EAU) Congress 2022.07

  11. Ishikawa Y, Uehara S, Ishihara K, Hirose K, Soma T, Fujiwara M, Kobayashi M, Fan B, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Variability in diagnostic performance of non-muscle invasive bladder cancer for each region using fluorescence cystoscopy with orally administered 5-aminolevulinic acid. the 37th Annual European Association of Urology(EAU) Congress 2022.07

  12. Fukuda S, Tanaka H, Tanabe K, Tamiya T, Kobayashi M, Yajima S, Nakamura Y, Fujiwara M, Ishikawa Y, Yamamoto T, Araki S, Yoshida S, Yokoyama M, Matsuoka Y, Otsuka Y, Koga F, Fujii Y. Local recurrence following partial nephrectomy in patients with renal cell carcinoma: a multicenter study. The 117th annual meeting of the American Urological Association 2022.05.13 New Orleans, USA

  13. Kobayashi M, Matsuoka Y, Uehara S, Tanaka Hiroshi, Nakamura Y, Uchida Y, Fukuda S, Tanaka Hajime, Yoshida S, Yokoyama M, Fujii Y. PIRADS score combined with positive core number on MRI-ultrasound fusion targeted prostate biopsy can predict the absence of pathological extraprostatic extension. AUA Annual Meeting 2022.05.13

  14. Uchida Y, Yokoyama M, Nakamura Y, Fukuda S, Uehara S, Tanaka H, Yoshida S, Matsuoka Y, Fujii Y. ASSESSMENT OF ERECTILE AND EJACULATORY FUNCTIONS AFTER BLADDER-SPARING THERAPY AGAINST MUSCLE-INVASIVE BLADDER CANCER. the 22nd World Meeting of the International Society for Sexual Medicine 2022.05

  15. 福島啓司、木島敏樹、吉田宗一郎、横山みなと、石岡淳一郎、松岡陽、斎藤一隆、松原伸晃、湯浅健、増田均、米瀬淳二、影山幸雄、藤井靖久. 進行尿路上皮癌症例におけるペムブロリズマブの治療効果及び予後：化学放射線療法の治療歴との関連. 第108回 日本泌尿器科学会総会 2020.12.24

  16. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Who benefits from extra-target sampling in addition to intra-target sampling for the detection of adverse prostate pathology?: Stereological analysis of biopsy-proven cancer sites. The 35th Annual Congress of the European Association of Urology 2020.07.17 Amsterdam Netherlands.

  17. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Who needs extra-target sampling in addition to intra-target sampling for the detection of adverse prostate pathology?: Spatial analysis of biopsy-proven cancer sites. The 115th annual meeting of the American Urological Association 2020.05.15 Washington DC, USA

  18. Matsuoka Y, Ishioka J, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Saito K, Fujii Y. Apparent diffusion coefficient ratio as a quantitative imaging marker: Utility in a nomogram for predicting biochemical recurrence after radical prostatectomy. The 115th annual meeting of the American Urological Association 2020.05.15 Washington DC, USA

  19. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Value of extra-target sampling in addition to intra-target sampling for the detection of prostate cancer upgrading according to PIRADS scores. 12th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer 2020.02.09 Washington DC, USA

  20. Rie Kato, Hiroshi Fukushima, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Ishioka Junichiro, Yoh Matsuoka, Kazutaka Saito, Yukihiro Otsuka, Fumitaka Koga, Masataka Yano, Tetsuro Tsukamoto, Hitoshi Masuda, Tetsuo Okuno, Junji Yonese, Katsushi Nagahama, Shigeyoshi Kamata, Akira Noro, Yukio Kageyama, Toshihiko Tsujii, Shinji Morimoto, Yasuhisa Fujii.. The qSOFA score outperforms the SIRS score in predicting in-hospital mortality of obstructive pyelonephritis patients: results from a multi-institutional study.. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

< PREV - NEXT >

To the head of this page.▲